The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against the Human Malaria Parasite Plasmodium falciparum via Polypharmacological Inhibition of Pf Ark1 and Hemozoin Formation is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
The National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: R01AI143521
The National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: R01AI185559
The National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: R01AI152092
Medicines for Malaria Venture (MMV) African Challenge Grant
Grant: RD-19-0001
Medicines for Malaria Venture (MMV) African Challenge Grant
Grant: RD-17-0047
Bill and Melinda Gates Foundation
Grant: OPP1054480
SA National Research Foundation
Grant: UID 84627
South African Medical Research Council
Fields of Study
Keywords
Sustainable Development Goals